Rocket Lab USA (RKLB) has soared 473% over the past year, fueled by strong revenue growth exceeding 50% in the last three ...

Today, Altitude Lab announced that its incubating startups have collectively raised $154 million in early-stage funding since its launch in 2020. Founded by Recursion, Altitude Lab supports diverse ...

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.

SALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Today, Altitude Lab announced that its incubating startups have collectively raised $154 million in early-stage funding since its launch in 2020.

Altitude Lab announces $154 million raised by startups, launches Gibson Fellowship for early-career scientists, and opens new applications. Altitude Lab announced that its startups have raised a ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Altitude Lab, a biotech accelerator formed by Recursion, on Wednesday announced the launch of a pre-seed venture fund to support early-stage startups affected by the changes in federal funding policy.

Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.